Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference ‘research perspectives in AF’
Open Access
- 17 June 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 30 (24) , 2969-2980
- https://doi.org/10.1093/eurheartj/ehp235
Abstract
Atrial fibrillation (AF) causes important mortality and morbidity on a population-level. So far, we do not have the means to prevent AF or AF-related complications adequately. Therefore, over 70 experts on atrial fibrillation convened for the 2nd AFNET/EHRA consensus conference to suggest directions for research to improve management of AF patients ( Supplementary Data ). The group defined three main areas in need for research in AF: 1. better understanding of the mechanisms of AF; 2. Improving rhythm control monitoring and management; and 3. comprehensive cardiovascular risk management in AF patients. The group put forward the hypothesis that successful therapy of AF and its associated complications will require comprehensive therapy. This applies e.g. to the “old” debate of “rate versus rhythm control”, since rhythm control is generally added to underlying (continued) rate control therapy, but also to the emerging debate of “antiarrhythmic drugs versus catheter ablation”, of which both may be needed in most patients to maintain sinus rhythm, but also to therapy of conditions that predispose to AF and contribute to cardiovascular complications such as stroke, cognitive decline, heart failure, and acute coronary syndromes. We call for research initiatives aiming at a better understanding of the different causes of AF and its complications, and at development and validation of mechanism-based therapies. The future of AF therapy may require a combination of management of underlying and concomitant conditions, early and comprehensive rhythm control therapy, adequate control of ventricular rate and cardiac function, and continuous therapy to prevent AF-associated complications (e.g. antithrombotic therapy). The reasons for these suggestions are detailed in this paper.Keywords
This publication has 128 references indexed in Scilit:
- Calcium Handling Abnormalities in Atrial Fibrillation as a Target for Innovative TherapeuticsJournal of Cardiovascular Pharmacology, 2008
- Repolarization and Activation Restitution Near Human Pulmonary Veins and Atrial Fibrillation Initiation: A Mechanism for the Initiation of Atrial Fibrillation by Premature BeatsPublished by Elsevier ,2008
- Comparison Between Tissue Doppler Imaging and Velocity-Encoded Magnetic Resonance Imaging for Measurement of Myocardial Velocities, Assessment of Left Ventricular Dyssynchrony, and Estimation of Left Ventricular Filling Pressures in Patients With Ischemic CardiomyopathyThe American Journal of Cardiology, 2008
- Subtle Neurological Abnormalities as Risk Factors for Cognitive and Functional Decline, Cerebrovascular Events, and Mortality in Older Community-Dwelling AdultsArchives of internal medicine (1960), 2008
- Mechanism of origin of conduction disturbances in aging human atrial bundles: Experimental and model studyHeart Rhythm, 2006
- Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trialsAmerican Heart Journal, 2006
- Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular eventsAmerican Heart Journal, 2006
- Age and the Risk of Warfarin‐Associated Hemorrhage: The Anticoagulation and Risk Factors In Atrial Fibrillation StudyJournal of the American Geriatrics Society, 2006
- Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial FibrillationAmerican Heart Journal, 2005
- Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathyThe American Journal of Cardiology, 2004